Literature DB >> 12439051

Current medical management of Graves ophthalmopathy.

Claudio Marcocci1, Luigi Bartalena, Michele Marinò, Roberto Rocchi, Barbara Mazzi, Francesca Menconi, Eugenia Morabito, Aldo Pinchera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12439051     DOI： 10.1097/00002341-200211000-00003

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN： 0740-9303            Impact factor:   1.746


× No keyword cloud information.
  4 in total

Review 1.  Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy.

Authors:  C Marcocci; M Marinò; R Rocchi; F Menconi; E Morabito; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

Review 2.  Pharmacological treatments for thyroid eye disease.

Authors:  Sara P Modjtahedi; Bobeck S Modjtahedi; Ahmad M Mansury; Dinesh Selva; Raymond S Douglas; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.

Authors:  Hao Wang; Li-Shuang Zhu; Jin-Wei Cheng; Ji-Ping Cai; You Li; Xiao-Ye Ma; Rui-Li Wei
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-11       Impact factor: 3.117

4.  Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect of methylprednisolone pulse therapy in patients with Graves' ophthalmopathy.

Authors:  Tien-Chun Chang; Yung-Lien Hsiao; Shu-Lang Liao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-26       Impact factor: 3.117
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.